(Q36997723)

English

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies

scientific article published on 12 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

1 reference

Europe PubMed Central

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

hepatic veno-occlusive disease

1 reference

based on heuristic

inferred from title

author name string

V T Ho

1

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

C Revta

2

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

P G Richardson

3

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

language of work or name

0 references

publication date

12 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

229-237

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705899

0 references

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Alteplase for hepatic veno-occlusive disease complicating bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Successful treatment of an infant with veno-occlusive disease developed after allogeneic bone marrow transplantation by tissue plasminogen activator, heparin and prostaglandin E1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Antithrombin treatment of severe hepatic veno-occlusive disease in children with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Anti-thrombin III in the management of hematopoietic stem-cell transplantation-associated toxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Low molecular weight heparin for the prevention of hepatic veno-occlusive disease (VOD) after hematopoietic stem cell transplantation: a prospective phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

21 January 2018

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention and treatment of hepatic venocclusive disease after high-dose cytoreductive therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic Veno-occlusive Disease (Sinusoidal Obstruction Syndrome) After Hematopoietic Stem Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of veno-occlussive disease in a cohort of multiple myeloma patients undergoing autologous stem cell transplantation with targeted busulfan dosage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide following Targeted Oral Busulfan as Conditioning for Hematopoietic Cell Transplantation: Pharmacokinetics, Liver Toxicity, and Mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Defibrotide, by enhancing prostacyclin generation, prevents endothelin-1 induced contraction in human saphenous veins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Defibrotide for the treatment of hepatic veno-occlusive disease in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Alteplase for hepatic veno-occlusive disease after bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Alteplase for hepatic veno-occlusive disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant tissue plasminogen activator (rt-PA) for veno-occlusive liver disease in pediatric autologous bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic veno-occlusive disease in pediatric stem cell recipients: successful treatment with continuous infusion of prostaglandin E1 and low-dose heparin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705899

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705899

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36997723&oldid=1665498746"